Islet transplantation in type 1 diabetes: hype, hope and reality - a clinician's perspective.


The β-cell replacement by islet transplantation is an attractive approach for normalizing blood glucose without hypoglycaemia in patient with type 1 diabetes mellitus (T1D). A pioneer study by the Edmonton group more than a decade ago showed that alloislet transplantation may result in insulin independence for at least 1 year after transplantation. This… (More)
DOI: 10.1002/dmrr.2484